92406-53-6

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 5-amino-1-methyl-1H-pyrazole-3-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs. Its unique structure and reactivity make it a valuable component in the creation of novel therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, methyl 5-amino-1-methyl-1H-pyrazole-3-carboxylate serves as an intermediate in the production of agrochemicals, aiding in the development of innovative agricultural products that can enhance crop protection and yield.
Used in Academic Research:
Methyl 5-amino-1-methyl-1H-pyrazole-3-carboxylate is utilized in academic research as a subject of study for its chemical properties and potential applications, contributing to the advancement of scientific knowledge in the field of chemistry and related disciplines.
Used in Chemical Manufacturing Processes:
methyl 5-amino-1-methyl-1H-pyrazole-3-carboxylate is also employed in chemical manufacturing processes, where it may be involved in the production of various chemical products, leveraging its structural and reactive characteristics to create a range of useful materials.

InChI:InChI=1/C6H9N3O2/c1-9-5(7)3-4(8-9)6(10)11-2/h3H,7H2,1-2H3

Upstream product

• 796038-07-8 1-methyl-5-nitro-1H-pyrazole-3-carboxylic acid methyl ester 
• 177409-38-0 2-methyl-5-nitro-2H-pyrazole-3-carboxylic acid methyl ester 
• 181585-93-3 5-nitro-1H-pyrazole-3-carboxylic acid methyl ester 
• 1227409-70-2 methyl 3-cyano-2-sodiumoxy-2-propenoate 
• 302-15-8 methylhydrazine sulfuric acid 
• 117860-55-6 3-(methoxycarbonyl)-1-methyl-1H-pyrazole-5-carboxylic acid 
• 203792-49-8 1-methyl-3-methoxycarbonylpyrazole-3-carboxylic acid chloride 
• 33146-99-5 methyl ester of 1-methylpyrazole-3,5-dicarboxylic acid 
• 117860-57-8 methyl 5-<(benzyloxycarbonyl)amino>-1-methylpyrazole-3-carboxylate 

Downstream Products

• 1193244-87-9 methyl 5-iodo-1-methyl-1H-pyrazole-3-carboxylate 
• 1227409-77-9 1-methyl-5-(quinolin-3-yl)-1H-pyrazol-3-carboxylic acid 
• 1227410-04-9 5-[1-(benzenesulfonyl)-1H-indol-3-yl]-1-methyl-N-[2-(morpholin-4-yl)ethyl]-1H-pyrazole-3-carboxamide 
• 1021497-96-0 1-methyl-5-(2-phenylsulfanyl-acetylamino)-1H-pyrazole-3-carboxylic acid methyl ester 
• 1021497-95-9 5-[2-(4-bromo-phenylsulfanyl)-acetylamino]-1-methyl-1H-pyrazole-3-carboxylic acid methyl ester 
• 117860-57-8 methyl 5-<(benzyloxycarbonyl)amino>-1-methylpyrazole-3-carboxylate 
• 92406-36-5 methyl 3-isopropoxycarbonyl-1,6-dimethyl-4-(3-nitrophenyl)-4,7-dihydropyrazolo[3,4-b]pyridine-5-carboxylate 
• 92406-34-3 methyl 3-methoxycarbonyl-1,6-dimethyl-4-(3-nitrophenyl)-4,7-dihydropyrazolo[3,4-b]pyridine-5-carboxylate 

Relevant academic research and scientific papers

COMPOUND HAVING ERK KINASE INHIBITORY ACTIVITY AND USE THEREOF

The invention relates to a compound of formula (I): wherein variables are as defined in the specification. The compound is an inhibitor of an ERK kinase, e.g. ERK1 and/or ERK2 kinase. The invention also relates to the use of the compound and a method for preparing the compound, and a pharmaceutical composition containing the compound.

NOVEL PYRAZOLE-3-CARBOXAMIDE DERIVATIVE HAVING 5-HT2B RECEPTOR ANTAGONIST ACTIVITY

Disclosed is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof, which is useful as a selective antagonist of a 5-HT2B receptor. The compound and salt are useful for treatment or prevention of various diseases and conditions associated with a 5-HT2B receptor.

AMINOPYRAZOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC DISEASES CONTAINING THE SAME

Provided are aminopyrazole derivatives, a process for the preparation thereof, and a composition for preventing or treating an ischemic disease containing the same. Since the aminopyrazole derivatives of the present invention can reduce an ischemic cell d

AMINOPYRAZOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC DISEASES CONTAINING THE SAME

The present invention relates to aminopyrazole derivatives, a process for the preparation thereof, and a composition for preventing or treating an ischemic disease containing the same. Since the aminopyrazole derivatives of the present invention can reduc

4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES

Disclosed are compounds of formula I and II that are bradykinin B1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.

Synthesis and Characterization of Masked Aminopyrazolecarboxylic Acid Synthons

The synthesis of the masked aminopyrazolecarboxylic acid synthons (11a,b and 12a,b) from pyrazole-3,5-dicarboxylic acid (6) and the determination of their structures by X-ray crystallography are detailed.The compounds are useful for the synthesis of polypyrazolecarboxamides analogous to the DNA minor groove binding antibiotics distamycin A and netropsin.

4,7-dihydropyrazolo(3,4-b) pyridine derivatives

Novel Ca-blockers, 4,7-dihydropyrazolo[3,4-b]pyridine derivatives having potent antihypertensive and coronary vasodilating actions and useful in treatment for diseases in circulatory system, but without systole inhibitory action.